Dietary glutamine supplementation modulates Th1/Th2 cytokine and interleukin-6 expressions in septic mice.
暂无分享,去创建一个
Wei-Jao Chen | C. Yeh | S. Yeh | Chun Hsu | Wei‐Jao Chen
[1] K. Pfeffer,et al. CECAL LIGATION AND PUNCTURE VERSUS COLON ASCENDENS STENT PERITONITIS: TWO DISTINCT ANIMAL MODELS FOR POLYMICROBIAL SEPSIS , 2004, Shock.
[2] Ming-Tsan Lin,et al. Effects of glutamine supplementation on innate immune response in rats with gut-derived sepsis , 2004, British Journal of Nutrition.
[3] Ming-Tsan Lin,et al. Glutamine supplementation enhances mucosal immunity in rats with Gut-Derived sepsis. , 2004, Nutrition.
[4] Ming-Tsan Lin,et al. Effects of dietary glutamine on antioxidant enzyme activity and immune response in burned mice. , 2003, Nutrition.
[5] M. Rincón,et al. The two faces of IL-6 on Th1/Th2 differentiation. , 2002, Molecular immunology.
[6] C. Hack,et al. Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. , 2002, Clinical immunology.
[7] P. Ducrotte,et al. Glutamine decreases interleukin-8 and interleukin-6 but not nitric oxide and prostaglandins e(2) production by human gut in-vitro. , 2002, Cytokine.
[8] P. Wischmeyer,et al. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. , 2001, Shock.
[9] C. Yeh,et al. Effects of glutamine-supplemented total parenteral nutrition on cytokine production and T cell population in septic rats. , 2001, JPEN. Journal of parenteral and enteral nutrition.
[10] D. Wilmore,et al. The effect of glutamine supplementation in patients following elective surgery and accidental injury. , 2001, The Journal of nutrition.
[11] E. Roth,et al. Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] W. Chang,et al. Effect of glutamine on Th1 and Th2 cytokine responses of human peripheral blood mononuclear cells. , 1999, Clinical immunology.
[13] P. Calder,et al. Glutamine and the immune system , 1999, Amino Acids.
[14] K. Reinhart,et al. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. , 1999, Critical care medicine.
[15] I. Chaudry,et al. What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? , 1999, Surgery.
[16] J. Kalbfleisch,et al. Early activation of hepatic NFkappaB and NF-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression, and mortality. , 1999, Annals of surgery.
[17] C. Deutschman,et al. Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[18] H. Maeta,et al. Wound Healing of Intestinal Anastomosis after Digestive Surgery under Septic Conditions: Participation of Local Interleukin-6 Expression , 1998, World Journal of Surgery.
[19] S. Vogel,et al. Pulmonary and Hepatic Gene Expression following Cecal Ligation and Puncture: Monophosphoryl Lipid A Prophylaxis Attenuates Sepsis-Induced Cytokine and Chemokine Expression and Neutrophil Infiltration , 1998, Infection and Immunity.
[20] D. Wilmore,et al. Role of glutamine in immunologic responses. , 1998, Nutrition.
[21] Lisa R Leon,et al. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.
[22] C. Deutschman,et al. Sepsis-induced depression of rat glucose-6-phosphatase gene expression and activity. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.
[23] P. Calder,et al. Glutamine requirement of proliferating T lymphocytes. , 1997, Nutrition.
[24] J. Dipiro. Cytokine Networks with Infection: Mycobacterial Infections, Leishmaniasis, Human Immunodeficiency Virus Infection, and Sepsis , 1997, Pharmacotherapy.
[25] John A. Mannick,et al. Major Injury Leads to Predominance of the T Helper‐2 Lymphocyte Phenotype and Diminished Interleukin‐12 Production Associated with Decreased Resistance to Infection , 1995, Annals of surgery.
[26] J. Meakins,et al. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. , 1995 .
[27] I. Chaudry,et al. Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. , 1994, The Journal of surgical research.
[28] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[29] R. Bone,et al. Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.
[30] P Franchimont,et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. , 1992, Annals of surgery.
[31] Z. Ba,et al. The Complex Pattern of Cytokines in Sepsis Association Between Prostaglandins, Cachectin, and Interleukins , 1991, Annals of surgery.
[32] T. Calandra,et al. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. , 1991, The American journal of medicine.
[33] P. Calder,et al. Does glutamine contribute to immunosuppression after major burns? , 1990, The Lancet.
[34] N. Webster,et al. T helper cell subset ratios in patients with severe sepsis , 1999, Intensive Care Medicine.
[35] T. Hirano. Interleukin 6 and its receptor: ten years later. , 1998, International reviews of immunology.
[36] W. Souba. Glutamine: a key substrate for the splanchnic bed. , 1991, Annual review of nutrition.
[37] L A Aarden,et al. Increased plasma levels of interleukin-6 in sepsis. , 1989, Blood.